Recent News

• 08.03.2026 - CENTOGENE APAC Expands Commitment to Taiwan’s Rare Disease Community
• 07.14.2026 - CENTOGENE takes ownership in Pearl Medical Analysis Lab in Abu Dhabi
• 07.01.2026 - CENTOGENE APAC Office Official Opening Ceremony in Taiwan
• 06.09.2026 - CENTOGENE at ESHG 2026
• 05.29.2026 - Reproductive Carrier Screening Portoflio Update
• 05.21.2026 - NEW Panel Portfolio CentoPediatric now available!
• 09.01.2025 - CENTOGENE at ESC 2025
• 06.17.2025 - CENTOGENE at ESHRE 2025
• 05.30.2025 - Extraordinary General Meeting of Shareholders of Crown LiquidationCo N.V.
• 05.30.2025 - Extraordinary General Meeting of Shareholders of Crown LiquidationCo N.V.

Recent Filings

• 01.10.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.05.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.19.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.13.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.06.2024 - SC 13G Statement of Beneficial Ownership by Certain Investors
• 10.30.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 10.16.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 10.15.2024 - 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
• 10.11.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 10.01.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]